Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Vycor Medical (VYCO) Shares Issued (2010 - 2017)

Vycor Medical (VYCO) reported Shares Issued of $666.0 for Q4 2017, down 99.92% on a QoQ basis from $842207.0 in Q1 2017.

Vycor Medical (VYCO) has 6 years of Shares Issued data on file, last reported at $666.0 in Q4 2017.

  • Quarterly Shares Issued changed N/A year-over-year to $666.0 in Q4 2017, while the trailing twelve-month figure through Sep 2018 was $666.0 (down 99.92% YoY) and the FY2017 annual result came in at $842873.0, changed N/A from the prior year.
  • Shares Issued fell to $666.0 in Q4 2017 per VYCO's latest filing, from $842207.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $4.1 million in Q1 2014 and bottomed at $666.0 in Q4 2017.
  • The 3-year median for Shares Issued is $842207.0 (2017), against an average of $1.2 million.
  • Peak annual rise in Shares Issued reached 43.04% in 2013, while the deepest fall reached 43.04% in 2013.
  • Tracing VYCO's Shares Issued over 3 years: stood at $28481.0 in 2013, then surged by 3164.84% to $929860.0 in 2014, then slumped by 99.93% to $666.0 in 2017.
  • Per Business Quant, the three latest VYCO Shares Issued figures stand at $666.0 (Q4 2017), $842207.0 (Q1 2017), and $929860.0 (Q2 2014).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 116.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 164.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 81.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 68.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 12.70 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Vycor Medical - - 375,153.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2017 -822,766.00
Dec 31, 2017 -822,766.00
Mar 31, 2017 842,207.00
Mar 31, 2017 842,207.00
Jun 30, 2014 929,860.00
Jun 30, 2014 929,860.00
Mar 31, 2014 4.07 Mn
Mar 31, 2014 4.07 Mn
Sep 30, 2013 28,481.00
Sep 30, 2013 28,481.00
Dec 31, 2012 -169,830.00
Dec 31, 2012 -169,830.00
Sep 30, 2012 50,000.00
Sep 30, 2012 50,000.00
Dec 31, 2011 443.00
Dec 31, 2011 443.00
Jun 30, 2011 745,000.00
Jun 30, 2011 745,000.00
Mar 31, 2011 144,000.00
Mar 31, 2011 144,000.00
Dec 31, 2010 520,000.00
Dec 31, 2010 520,000.00
Sep 30, 2010 165,000.00
Sep 30, 2010 165,000.00